PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|4|1|44-58

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.4, Iss.1, 2011-01, pp. : 44-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase type 4 that regulates cAMP level in cortical neurons shows high sensitivity to rolipram

By Yamashita N.   Yamauchi M.   Baba J.   Sawa A.  

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol

By Sasaki H.   Hashimoto K.   Inada T.   Fukui S.   Iyo M.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 71-76

Elsevier

Access to resources Recommend Favorite

cAMP-Mediated Regulation of CYP Enzymes and Its Application in Chemotherapy

By  

Drug Metabolism Letters, Vol. 1, Iss. 3, 2007-08 ,pp. : 176-178

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Phosphodiesterase 4-Mediated Cyclic AMP Signaling in Pharmacotherapy for Substance Dependence

By  

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 355-364

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Inducible Nitric Oxide Synthase by cAMP-Elevating Phosphodiesterase Inhibitors

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 1, 2003-01 ,pp. : 63-79

Bentham Science Publishers

Access to resources Recommend Favorite